Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • kgulukota
    Member
    • Oct 2011
    • 30

    #1

    Just how much is genetic related anyway?

    Roberts et al have analyzed large cohorts of monozygotic twins to try and determine the theoretical limits of how useful genomic sequencing can be.



    Amid the breathless anticipation about the $1000 genome and beyond, it is sobering to remember what we knew all along: there is PLENTY of environmental effects on how we turn out.

    Even if we could sequence and analyze genomes for negligible cost, there still remains a significant hurdle: lack of knowledge about what genetic variation really means for phenotype.

    I guess we should be happy: our jobs are safe for the foreseeable future.
    Kamalakar Gulukota,
    Director,
    Center for Bioinformatics and Computational Biology
    NorthShore University Health System, [email protected]
  • Joann
    Senior Member
    • Oct 2008
    • 230

    #2
    Hi Gulu,

    I think newborn screening applications (for detecting and treating the many treatable genetic diseases at birth) will be a good start. US state public health departments are recognizing the potential of switching from gene panels to whole genome sequencing.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
      by SEQadmin2




      NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
      Today, 06:46 AM
    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-28-2026, 09:57 AM
    0 responses
    22 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-28-2026, 09:51 AM
    0 responses
    15 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 11:13 AM
    0 responses
    68 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 10:48 AM
    0 responses
    48 views
    0 reactions
    Last Post SEQadmin2  
    Working...